Earlier this year, the FDA had already eased restrictions on the requirement of in-person assessment for drug-induced abortion due to the coronavirus pandemic. The abortion industry and its allies quickly readied tele-abortion services to be utilized on a permanent basis.
In April 2020, Planned Parenthood CEO Alexis McGill Johnson referred to telemedicine abortion as the “silver lining” of the coronavirus pandemic.
Johnson told Democracy Now’s Amy Goodman the fact that many states had attempted to include elective abortions among other procedures that should be temporarily banned to preserve scarce medical equipment for healthcare workers treating coronavirus patients was “unconscionable.”
The CEO of the nation’s largest abortion provider boasted the launch of Planned Parenthood’s new tele-abortion service, in which women seeking the procedure have a virtual meeting with a provider and obtain a prescription for abortion-inducing drugs they take at home.
Developing Story - Trump administration oversaw a RADICAL change to the tech world… one that could unleash a huge wave prosperity… and wealth creation in the near future. Find Out More
“It is actually a silver lining in this pandemic, that Planned Parenthood and many other health providers have actually been able to really lean into telehealth infrastructure and provide service,” she said.
Dr. Meera Shah, chief medical officer of Planned Parenthood Hudson Peconic, touted to the Associated Press (AP) in April 2020 that her organization’s new telemedicine abortion service is so much in demand that one mother began her drug-induced abortion “at home with her children running around behind her.”
Former abortionist Dr. Anthony Levatino explained in his videos about various abortion procedures how drug-induced abortions work.
The first drug, mifepristone, blocks the action of progesterone, which the mother’s body produces to nourish the pregnancy. When progesterone is blocked, the lining of the mother’s uterus deteriorates, and blood and nourishment are cut off to the developing baby, who then dies inside the mother’s womb.
The drug misoprostol (also called Cytotec) then causes contractions and bleeding to expel the baby from the mother’s uterus.
This series of events now occurs at home when women and girls have the drugs mailed to them.
“We really strongly feel folks should have the abortion experience that they want, and that can mean a number of different things,” Dr. Colleen McNicholas, chief medical officer for reproductive health services of Planned Parenthood of the St. Louis Region, said, according to the Chicago Tribune.
States that already restrict abortions may not experience an impact from the FDA’s move, the pro-abortion rights Guttmacher Institute says.
In 32 states, for example, non-physicians are not allowed to provide the drugs needed for termination, while in 19 states clinicians must be physically present when the drugs are administered to end the pregnancy.
Planned Parenthood tweeted the FDA’s decision is a “WIN” since it makes access to abortion easier.
“By eliminating medically unnecessary restrictions, patients in many states can access medication abortion in the privacy of their own home,” the nation’s largest abortion provider celebrated.
The American Civil Liberties Union (ACLU) continued the narrative that the restriction on mifepristone is unnecessary and even criticized FDA for “falling short of repealing all unjustified restrictions on this safe medication.”
Pro-life groups, however, have opposed lifting restrictions on drug-induced abortions, citing dangers of young women taking the drugs that ultimately lead to considerable bleeding and contractions while alone, for example, in college dorms.
A study published in November by the Charlotte Lozier Institute, the research arm of the Susan B. Anthony List, found drug-induced abortion is “consistently and progressively associated with more postabortion emergency room visit morbidity than surgical abortion.”
“There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion,” the researchers concluded.
The study determined chemical abortion visit rates increased by 507 percent between 2002 and 2015, the same period of time during which the surgical abortion visit rate rose 315 percent.